Risperidone versus typical antipsychotic medication for schizophrenia
about
Risperidone (depot) for schizophreniaHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersZuclopenthixol versus placebo for schizophreniaQ24197685Haloperidol versus first generation antipsychotics for schizophreniaHaloperidol dose for the acute phase of schizophreniaPaliperidone palmitate for schizophreniaAntipsychotic drug treatment for elderly people with late-onset schizophreniaRisperidone for psychosis induced aggression or agitationRisperidone versus placebo for schizophreniaOral paliperidone for schizophreniaPaliperidone for schizophreniaOlanzapine for schizophreniaPolyunsaturated fatty acid supplementation for schizophreniaRisperidone versus olanzapine for schizophreniaAmphetamines for schizophreniaQuetiapine for schizophreniaTrifluoperazine for schizophreniaOmega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Clinical utility of the risperidone formulations in the management of schizophrenia.Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness.Ziprasidone for schizophrenia and severe mental illness.Definitions and drivers of relapse in patients with schizophrenia: a systematic literature reviewChlorpromazine dose for people with schizophrenia.Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases.Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada.Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.The German Research Network on Schizophrenia--impact on the management of schizophreniaTreatment resistant schizophrenia: a comprehensive survey of randomised controlled trials.A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophreniaRethinking antipsychotic formulary policy.Combination therapy or monotherapy for the depressed type of schizoaffective disorder.Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics.Evaluating appropriateness of prescribing of long-acting risperidone for injection in acute care settings.Bifeprunox versus placebo for schizophrenia.Patients' health literacy in psychotic disordersEfficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study.A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia.Comparator bias: why comparisons must address genuine uncertainties.Risperidone versus placebo for schizophrenia
P2860
Q24185901-F4AA269A-8D7E-453C-BB8E-D28C26656DACQ24186601-0D548AF7-4862-4CFB-84C2-2976E1DF4E1AQ24187287-61260281-5D27-4195-BB99-F429713A942BQ24197685-54C1BCC2-42E3-4D4E-86F2-E9269EE39781Q24198264-529538F8-9A6C-4681-ADF5-75F6F7498F07Q24200200-BA1CDC22-905E-4A78-A636-C8D1357BE984Q24202846-F1033874-D115-480E-BC75-141DD878273AQ24203649-9BBAC728-48FB-43AE-8E9B-489DF438F477Q24235440-781253F0-EBC6-4294-A6B4-7D985E2357C4Q24241041-DED9B0FB-31C1-402E-ABB9-67675B0DC36CQ24242948-C325D091-37E6-44EF-9163-F5EE2D9674A0Q24243556-8E5C82FF-91E8-4885-AB63-D7CFC472AF8AQ24244031-1AAD90A9-ABE6-41BE-A493-12FD207023CDQ24245513-E7BC5BDB-58BA-46F1-B311-13728CA9AF59Q24246232-DAC7AC91-B470-4222-AC5A-D65E8D6E86BBQ24246723-F111C636-7F89-4F26-A4DF-82AE49BEFD2EQ24247154-896A77C8-6BEC-42A8-8A47-A786FEB07826Q24247440-7C4759F6-2655-43C1-8CBA-050184B544DDQ24681087-C2FE096E-7FBB-44C6-91B0-5B8AA046B4F5Q30429721-4D625A91-B0C9-4206-9570-02D0E4B4D36FQ30759036-9E41838D-AFDC-4D42-A053-31FF24C70890Q30868078-1925C8C9-4636-4F37-8474-7BDDDCBBBBA6Q33589087-F3318E05-5ADB-4267-A57F-B5437F9FA1D9Q34681498-8F25EF8F-9AE1-4CCA-A87A-2EF8C186C9BCQ34693244-842A0411-ECE5-4B01-99CB-5CF16DB6EA10Q34746791-F0DF2957-0D9D-42C4-993E-B1AACE9A83B1Q35061441-95F4CB5B-058C-4FF7-A80D-6208AE11BE29Q35236670-CAF62D65-05EE-4DFF-99AD-F5B93147E787Q35256929-EEF87A8B-A48C-4E93-AC72-39E85F87DF77Q35732320-676F5BFE-DB34-470D-88D5-6E744864EFC8Q36883316-66A0D2DA-1731-4C8F-950B-C6211806CAB9Q37224567-38446F6F-A159-498C-9140-67F97700545DQ37511776-2B4AECB4-7F88-426E-A0BE-921C82C13F57Q38000246-1457CACD-3248-4566-9539-32BBF5636A59Q38978909-CE499364-BDA1-4CF2-9F45-64F1738E64C2Q42255125-F2289B11-24B5-4A47-B1BC-123DCB528A07Q47137102-206DBE0A-641D-4087-B1F3-7904128622FBQ47827614-5A42E320-BFA9-41D7-8685-7A2549055A3FQ53113470-3B03C3C0-99F3-440B-A9E7-FCD780BDFE5BQ55894951-B8A65E24-32D3-4A9A-ACCA-1E005EF2B45B
P2860
Risperidone versus typical antipsychotic medication for schizophrenia
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Risperidone versus typical antipsychotic medication for schizophrenia
@ast
Risperidone versus typical antipsychotic medication for schizophrenia
@en
Risperidone versus typical antipsychotic medication for schizophrenia
@en-gb
Risperidone versus typical antipsychotic medication for schizophrenia
@nl
type
label
Risperidone versus typical antipsychotic medication for schizophrenia
@ast
Risperidone versus typical antipsychotic medication for schizophrenia
@en
Risperidone versus typical antipsychotic medication for schizophrenia
@en-gb
Risperidone versus typical antipsychotic medication for schizophrenia
@nl
altLabel
Risperidone versus typical antipsychotic medication for schizophrenia.
@ast
Risperidone versus typical antipsychotic medication for schizophrenia.
@en
prefLabel
Risperidone versus typical antipsychotic medication for schizophrenia
@ast
Risperidone versus typical antipsychotic medication for schizophrenia
@en
Risperidone versus typical antipsychotic medication for schizophrenia
@en-gb
Risperidone versus typical antipsychotic medication for schizophrenia
@nl
P2093
P2860
P1476
Risperidone versus typical antipsychotic medication for schizophrenia
@en
P2093
P2860
P304
P356
10.1002/14651858.CD000440
P407
P50
P577
2000-01-01T00:00:00Z